{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:11:10Z","timestamp":1770271870463,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013786","name":"Cure EB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008081","name":"DebRA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.12.050","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:37:45Z","timestamp":1767703065000},"page":"655-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A safer path to gene correction in junctional epidermolysis bullosa"],"prefix":"10.1016","volume":"34","author":[{"given":"Aidin","family":"Kazemizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-7896","authenticated-orcid":false,"given":"Joanna","family":"Jack\u00f3w-Malinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.050_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fmed.2018.00363","article-title":"Junctional Epidermolysis Bullosa: Allelic Heterogeneity and Mutation Stratification for Precision Medicine","volume":"5","author":"Condrat","year":"2019","journal-title":"Front Med."},{"key":"10.1016\/j.ymthe.2025.12.050_bib2","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2025.02.040","article-title":"Gene therapy then and now: A look back at changes in the field over the past 25 years","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.050_bib3","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2025.12.050_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ymthe.2025.10.054","article-title":"Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa","volume":"34","author":"Hierl","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.050_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.matbio.2018.04.001","article-title":"Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone","volume":"71\u201372","author":"Has","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2025.12.050_bib6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","article-title":"On- and off-target effects of paired CRISPR-Cas nickase in primary human cells","volume":"32","author":"Klermund","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.050_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41586-019-1085-7","article-title":"Stem cell competition orchestrates skin homeostasis and ageing","volume":"568","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.050_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(25)00778-0","article-title":"Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial","volume":"406","author":"Tang","year":"2025","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2025.12.050_bib9","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","article-title":"Perturb-seq: Dissecting molecular circuits with scalable single cell RNA profiling of pooled genetic screens","volume":"167","author":"Dixit","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.050_bib10","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.cell.2024.03.020","article-title":"Chromatin context-dependent regulation and epigenetic manipulation of prime editing","volume":"187","author":"Li","year":"2024","journal-title":"Cell"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:40:27Z","timestamp":1770223227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1525001625010731"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.050","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A safer path to gene correction in junctional epidermolysis bullosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.054","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}